Effect of Mycophenolate Mofetil on the Pharmacokinetics of Antiretroviral Drugs and on Intracellular Nucleoside Triphosphate Pools
- 1 January 2004
- journal article
- clinical trial
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 43 (12) , 823-832
- https://doi.org/10.2165/00003088-200443120-00004
Abstract
Objective To study the effect of mycophenolate mofetil therapy on the pharmacokinetic parameters of a number of antiretroviral drugs, on intracellular pools of deoxycytidine triphosphate (dCTP) and...Keywords
This publication has 34 references indexed in Scilit:
- Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometryJournal of Mass Spectrometry, 2003
- Solid-Organ Transplantation in HIV-Infected PatientsNew England Journal of Medicine, 2002
- Development of Enzymatic Assays for Quantification of Intracellular Lamivudine and Carbovir Triphosphate Levels in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus-Infected PatientsAntimicrobial Agents and Chemotherapy, 2002
- Pharmacokinetics and pharmacodynamics of mycophenolic acid in stable renal transplant recipients treated with low doses of mycophenolate mofetilTransplant International, 2000
- Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral TherapyNew England Journal of Medicine, 1999
- Clinical Pharmacokinetics of Mycophenolate MofetilClinical Pharmacokinetics, 1998
- Hydroxyurea as an Inhibitor of Human Immunodeficiency Virus-Type 1 ReplicationScience, 1994
- Immunosuppressive and other Effects of Mycophenolic Acid and an Ester Prodrug, Mycophenolate MofetilImmunological Reviews, 1993
- Pharmacokinetics of nevirapine: initial single-rising-dose study in humansAntimicrobial Agents and Chemotherapy, 1993
- HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structureCell, 1990